Product Information
CETIRIZINE HCL 5 MG CHEW TAB is a generic product labeled by Sandoz Inc., priced at $1.9921 per EA under NDC 00781528364. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 14, 2008.
The High Outlier badge above means this manufacturer's average price in the Cetirizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Sandoz Inc.NDC
00781528364
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078692FDA Approved
2/14/2008
On Market Since
2/14/2008
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 5 MG CHEW TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9921 per EA |
|---|---|
| All-time high | $4.1494 (Jul 12, 2017) |
| All-time low | $1.4032 (Feb 17, 2021) |
| 52-week high | $2.2133 |
| 52-week low | $1.9916 |
| Median price | $2.0026 |
| Average price | $2.1127 |
| Largest weekly change | +128.2% (Jul 22, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 5 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 5 MG CHEW TAB, manufactured by Sandoz Inc., is $1.9921 per EA (NDC 00781528364), effective Sep 30, 2026.
How has the price of CETIRIZINE HCL 5 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 5 MG CHEW TAB has risen 17.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 5 MG CHEW TAB?
Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 5 MG CHEW TAB has ranged from a low of $1.4032 (Feb 17, 2021) to a high of $4.1494 (Jul 12, 2017), with a median of $2.0026 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 5 MG CHEW TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CETIRIZINE HCL 5 MG TABLET, is $0.0476 per EA — about 98% below CETIRIZINE HCL 5 MG CHEW TAB.
Who manufactures CETIRIZINE HCL 5 MG CHEW TAB?
CETIRIZINE HCL 5 MG CHEW TAB (NDC 00781528364) is labeled by Sandoz Inc., and CMS classifies it as a generic product.